FLUENT BIOSCIENCES INC — Department of Health and Human Services SBIR Phase II: 400

FLUENT BIOSCIENCES INC — SBIR Phase II award from Department of Health and Human Services.

Amount
$1,146,224
Agency
Department of Health and Human Services · National Institutes of Health
Program / Phase
SBIR · Phase II
Topic
400
Solicitation
PA22-176
NAICS
Place of performance
MA
Period
2023-09-01 → 2025-07-31

Description

PROJECT SUMMARY / ABSTRACT Single-cell RNA sequencing (scRNAseq) provides unprecedented insight into the gene regulatory pathways of living cells in complex tissues. Fluent BioSciences has developed Pretemplated Instant Partitioning for single-cell RNA sequencing (PIPseq) that eliminates the cost and complexity of bespoke microfluidics and instrumentation and features a simple, flexible workflow that can be implemented in any laboratory setting. With Phase I SBIR support (1 R43 GM137648-01A1) we have demonstrated that PIPseq is intrinsically scalable and is capable of capturing from hundreds to millions of cells in a single reaction. The advent of new, high capacity, and low cost sequencing modalities such as that developed by Ultima Genomics makes high cell-input single cell transcriptomics not only feasible but practical, enabling previously inaccessible experimental modalities. In this proposal, we will expand the capabilities of PIPseq single cell analysis to provide simple, scalable, and cost-effective solutions for high cell input applications including deep tissue profiling, multiplexed drug testing, and pooled CRISPR screening.